Chemical Properties
| form | Liquid |
| color | Colorless to light yellow |
Lutikizumab Chemical Properties,Usage,Production
Uses
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis[1].in vivo
Lutikizumab (0.0001-1 mg/kg, i.p., once) shows effective inhibition to the IL-6 production induced by IL-1α and IL-1β[1].
| Animal Model: | Female C57/BL6 mice with IL-1α and IL-1β injection[1] |
| Dosage: | 0.0001-1 mg/kg |
| Administration: | Intraperitoneal injection, 0.0001-1 mg/kg, once |
| Result: | Dose-dependently decreased the murine IL-6 generated by human and cynomolgus IL-1α and IL-1β. |
References
[1] Lacy SE, et al. Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β. MAbs. 2015;7(3):605-19. DOI:10.1080/19420862.2015.1026501Lutikizumab Suppliers
Global(13)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| +1-631-485-4226 | inquiry@bocsci.com | 19934 | 58 | ||
| 027-87008169 17762441161 | info@atagenix.com | 9997 | 58 | ||
| 010-60605840 | psaitong@jm-bio.com | 27756 | 58 | ||
| 9785721070 | info@cellsciences.com | 6307 | 58 | ||
| 51288865780 | sales@biosynth.com | 6031 | 58 | ||
| 027-65279366 18108604356 | products@biolabreagent.com | 9864 | 58 | ||
| 027-65317797 15926423062 | 422450190@qq.com | 10300 | 58 | ||
| 177-54423994 17754423994 | 2853530910@QQ.com | 7999 | 62 | ||
| 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | 7353 | 58 | ||
| 17316404525 17316404525 | 209533805@qq.com | 9790 | 58 |